Effects of the copper intrauterine device and injectable progestogen contraceptive on depression and sexual functioning

A randomised control trial studying the effects of the copper intrauterine device and injectable progestogen contraceptive on depression and sexual functioning of women in the Eastern Cape

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201210000420221

Enrollment

200

Registered

2012-09-26

Start date

2012-10-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth depression,sectual functioning

Interventions

Copper T380A

(Injectable progestogen group - DMPA

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women of child bearing age between 18 to 35 years Women with no evidence of active pelvic infection Women who have no contraindications to injectable Progestogen or IUD Women who are prepared to use either method of contraception Women delivered less than 48 ago. Women who are willing and able to give consent.

Exclusion criteria

Exclusion criteria: Recent noticed vaginal bleeding that is unusual. Any contraindication for deport injection and IUD as stated on the WHO contraceptive eligibility criteria will. Women at baseline screening with depression score of 29 - 63(severe depression) Women with no access to telephone

Design outcomes

Primary

Measure	Time frame
depression and sexual functioning	—

Countries

South Africa

Contacts

Public ContactMandisa Singata

Deputy Director

mandisa.singata@gmail.com+27 43 708 2134

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026